| 000 | 01195nam a2200277zi 4500 | ||
|---|---|---|---|
| 005 | 20200318115101.0 | ||
| 008 | 051017s1974 xxua 000 0 eng | ||
| 020 | _a0890040117 | ||
| 035 | _aMX001001044409 | ||
| 040 |
_aDLC _bspa _cDLC _dUNAM |
||
| 050 | 0 |
_aRM405 _bP63 |
|
| 245 | 0 | 0 |
_aProstaglandin synthetase inhibitors : _btheir effects on physiological functions and pathological states ; sponsored jointly by the Royal Society of Medicine Foundation, Inc. of New York and the Royal Society of Medicine of London, held November 28-30, 1973 at the Rockefeller, University, New York City / _ceditors Harry J. Robinson, John R. Vane |
| 264 | 1 |
_aNew York : _bRaven, _cc1974 |
|
| 300 |
_a395 páginas : _bilustraciones |
||
| 650 | 0 |
_aAspirina _vCongresos |
|
| 650 | 0 |
_aAgentes antiinflamatorios _vCongresos |
|
| 650 | 0 |
_aProstaglandinas _vCongresos |
|
| 700 | 1 |
_aRobinson, Harry Joseph _d1909- , _eeditor |
|
| 700 | 1 |
_aVane, John R., _eeditor |
|
| 710 | 2 | _aRoyal Society of Medicine Foundation | |
| 710 | _aRoyal Society of Medicine (Gran Bretaña) | ||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 999 |
_c4039 _d4039 |
||